ProfileGDS4718 / 206032_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 13% 19% 25% 14% 18% 18% 82% 16% 17% 14% 15% 23% 15% 20% 22% 22% 16% 15% 57% 49% 15% 18% 23% 15% 16% 18% 14% 56% 15% 21% 79% 16% 18% 15% 19% 35% 88% 22% 19% 15% 14% 87% 26% 87% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.9068513
GSM549102patient 115, normal, homogenized [OPG study]4.1253619
GSM549104patient 119, normal, homogenized [OPG study]4.3121625
GSM549108patient 138, normal, homogenized [OPG study]3.9602814
GSM549119patient 077, normal, homogenized [OPG study]4.0635418
GSM549133patient 032, cancer, homogenized [OPG study]4.0201818
GSM549139patient 042, cancer, homogenized [OPG study]8.0815282
GSM549099patient 107, normal, homogenized [OPG study]3.9985216
GSM549109patient 139, normal, homogenized [OPG study]4.0461217
GSM549110patient 046, normal, homogenized [OPG study]3.9155714
GSM549114patient 063, normal, homogenized [OPG study]3.9472615
GSM549122patient 082, normal, homogenized [OPG study]4.2558123
GSM549134patient 033, cancer, homogenized [OPG study]3.966815
GSM549136patient 036, cancer, homogenized [OPG study]4.0846520
GSM549140patient 044, cancer, homogenized [OPG study]4.1984422
GSM549111patient 047, normal, homogenized [OPG study]4.2123922
GSM549113patient 057, normal, homogenized [OPG study]3.9354916
GSM549132patient 031, cancer, homogenized [OPG study]3.9567715
GSM549137patient 038, cancer, homogenized [OPG study]5.9074857
GSM549142patient 047, cancer, homogenized [OPG study]5.5793449
GSM549100patient 110, normal, homogenized [OPG study]3.955315
GSM549107patient 135, normal, homogenized [OPG study]4.051318
GSM549115patient 068, normal, homogenized [OPG study]4.1985923
GSM549116patient 072, normal, homogenized [OPG study]3.94515
GSM549120patient 078, normal, homogenized [OPG study]3.9767816
GSM549131patient 030, cancer, homogenized [OPG study]4.0366318
GSM549118patient 074, normal, homogenized [OPG study]3.9255714
GSM549129patient 027, cancer, homogenized [OPG study]5.8736656
GSM549123patient 088, normal, homogenized [OPG study]3.9537415
GSM549124patient 006, cancer, homogenized [OPG study]4.2110821
GSM549126patient 015, cancer, homogenized [OPG study]7.8020279
GSM549128patient 025, cancer, homogenized [OPG study]3.9902616
GSM549103patient 117, normal, homogenized [OPG study]4.0933418
GSM549117patient 073, normal, homogenized [OPG study]3.9619615
GSM549138patient 041, cancer, homogenized [OPG study]4.0969319
GSM549141patient 045, cancer, homogenized [OPG study]4.6810135
GSM549130patient 028, cancer, homogenized [OPG study]8.7606788
GSM549101patient 111, normal, homogenized [OPG study]4.220122
GSM549105patient 128, normal, homogenized [OPG study]4.1101419
GSM549106patient 134, normal, homogenized [OPG study]3.9160415
GSM549112patient 048, normal, homogenized [OPG study]3.9318714
GSM549125patient 011, cancer, homogenized [OPG study]8.664887
GSM549127patient 024, cancer, homogenized [OPG study]4.3562126
GSM549135patient 035, cancer, homogenized [OPG study]8.8752787